Lanean...
The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
The recent accelerated approval for use in extensively drug-resistant and multidrug-resistant-tuberculosis (MDR-TB) of two first-in-class TB drugs, bedaquiline and delamanid, has reinvigorated the TB drug discovery and development field. However, although several promising clinical development progr...
Gorde:
| Argitaratua izan da: | Cold Spring Harb Perspect Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cold Spring Harbor Laboratory Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4448709/ https://ncbi.nlm.nih.gov/pubmed/25635061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a021154 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|